| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 666288 | Null | 0.0223138217461955 | 0.089561235 |
| NSC 666869 | Null | 0.0223138217461955 | 0.16777147 |
| NSC 674071 | Null | 0.0223138217461955 | 0.13408599 |
| NSC 674233 | Null | 0.0223138217461955 | 0.055371122 |
| NSC 676006 | Null | 0.0223138217461955 | 0.18848721 |
| NSC 677003 | Null | 0.0223138217461955 | 0.13542542 |
| NSC 678994 | 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- | 0.0223138217461955 | 0.14884024 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.0223138217461955 | 0.32812986 |
| NSC 694493 | 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-pyridinyl)- | 0.0223138217461955 | 0.24249712 |
| NSC 704213 | Methanesulfonamide, N-[3-methyl-7-(phenylmethoxy)-1-(phenylsulfonyl)- 1H-indol-5-yl]- | 0.0223138217461955 | 0.3141944 |